Press releases in 2023
12. 12. 2023 |
The first stage of the construction of Lek's new high-tech biopharmaceutical production center was launched today in Lendava with the assembly of a DNA double helix to commemorate the70th anniversary ...
8. 12. 2023 |
Lek, a Sandoz company and a leading producer of generics and biosimilars, has once again received the Best of the Best award for business practice, presented by AmCham Slovenia. The ...
24. 11. 2023 |
As one of the most reputable employers in Slovenia, Lek is consistently recognized for its HR practices. Its latest accolade is the TOP Education Investor certificate, awarded by Planet GV ...
16. 10. 2023 |
Prof. Zdenko Časar, PhD, Head of Early Stage Development at Lek, has been awarded the Puh Award for his outstanding work in the field of industrial pharmaceutics. It is the ...
4. 10. 2023 |
Sandoz, the global leader in generic and biosimilar medicines, today celebrates the start of share trading on the SIX Swiss Exchange as an independent company.
20. 9. 2023 |
Yesterday,the Chamber of Commerce and Industry of Slovenia presented awards for the bestinnovations in the country. Atthe Innovation Day held at Brdo pri Kranju, Lek received a gold and a bronzeaward ...
12. 9. 2023 |
Between September 7 and 10, Lek, a Sandoz company, hosted ScienceBEAT, a world-class scientific and professional event aimed at promising natural sciences and business students from Slovenia and abroad. Over ...
30. 8. 2023 |
In Laško, the Sports Federation for the Disabled of Slovenia – Slovenian Paralympic Committee organized the traditional Pralympic Camp for Families, where young people with disabilities and their families learned ...
4. 8. 2023 |
Pursuant to Article 147 of Market in Financial Instruments Act (Official Gazette of the Republic of Slovenia No. 77/2018, as amended, "ZTFI-1"), in conjunction with Article 140(2) of ZTFI-1, Lek ...
20. 7. 2023 |
Sandoz, a global leader in generic and biosimilar medicines, today announced an investment of approximately USD 90 million at its site in Ljubljana, Slovenia to establish a dedicated Sandoz Biopharma ...
30. 6. 2023 |
Record investments in advanced environmental solutions and extensive acquisition of new employee skills are key features of the results of Novartis's management of sustainable aspects of business in the past ...
29. 6. 2023 |
The Supervisory Board of Lek approved the changes to the membership of the company's Board of Management at its meeting at the end of June, following a proposal by Robert ...
5. 6. 2023 |
Today, Novartis in Slovenia, which includes Lek, a Sandoz company, raised the rainbow flag in Ljubljana and Mengeš in support of Pride Month. This symbolic act demonstrates the company's support ...
18. 5. 2023 |
Lek, a Sandoz company, in cooperation with the Ljubljana University Incubator, the Spirit agency, the University of Ljubljana, the University of Maribor and the University of Primorska, is organizing ScienceBEAT, ...
18. 4. 2023 |
Lek has been awarded the prestigious Most Reputable Employer title for the fourth year in a row by the employment portal MojeDelo.com. According to the participants in the employer reputation ...
9. 3. 2023 |
The investment in a high-tech production center for biosimilars is the largest single investment in Lek's history and is also one of the largest ever in the Slovenian economy. Lek ...
1. 2. 2023 |
Novartis in Slovenia, which includes Lek d.d., Sandoz d.d. and Novartis Pharma Services Inc., Podružnica v Sloveniji has maintained its leading position on the Slovenian pharmaceutical market despite the difficult ...
17. 1. 2023 |
Novartis in Slovenia has once again received the prestigious international "Top Employer" certificate for one of the best employers at both the Slovenian and European levels, awarded by the Top ...